JCRB0163 HL60(S)
Cell information
Cell type:general cells (View Pricing Information)
| JCRB No. | JCRB0163 | Cell Name | HL60(S) |
|---|---|---|---|
| Profile | Promyeloblastic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. This HL60(S) has been independently obtained by Dr. Ishida,S. and Dr. Shudo,K. | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | F | Age | 36 |
| Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
| Case history | acute promyelotic leukemia | Metastasis | |
| Tissue Metastasized | Genetics | APL | |
| Life Span | infinite | Crisis PDL | |
| Morphology | lymphocyte-like | Character | DMSO, butyl, HX., TPA, active vitamine D3, and Retinoic Acid induce differentiation efficiently. |
| Classify | tumor | Established by | Collins,S.J. et al. |
| Registered by | Shudo,K. | Regulation for Distribution | free |
| Comment | STR-PCR results indicated the HL60(S) is the same with HL60(JCRB0085) | Year | 2000 |
| Medium | RPMI1640 medium with 5% fetal bovine serum (heat inactivation may be done). | Methods for Passages | Simple dilution. Subculture every 3 days. |
| Cell Number on Passage | 1 x 10^5 cells/ml | Race | Cocasian |
| CO2 Conc. | 5 % | Tissue Sampling | peripheral blood |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:7944409 | Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80. Takahashi N,Breitman TR Arch Biochem Biophys. 1994 Oct;314(1):82-9 |
| Pubmed id:3184125 | Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. Kagechika H,Kawachi E,Hashimoto Y,Himi T,Shudo K J Med Chem. 1988 Nov;31(11):2182-92 |
| Pubmed id:6192693 | Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation. Hozumi M Adv Cancer Res. 1983;38():121-69 |
| Pubmed id:288488 | Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Gallagher R,Collins S,Trujillo J,McCredie K,Ahearn M,Tsai S,Metzgar R,Aulakh G,Ting R,Ruscetti F,Gallo R Blood. 1979 Sep;54(3):713-33 |
| Pubmed id:271272 | Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Collins SJ,Gallo RC,Gallagher RE Nature. 1977 Nov 24;270(5635):347-9 |
| Images |
|---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB0163 | Cell Name | |
|---|---|---|---|
| LOT No. | 07292004 | Lot Specification | distribution |
| Medium | RPMI1640 medium with 10% fetal bovine serum. At log growth phase, serum contents can be decreased to 5%. (FBS lot; GIBCO 3762782S) | Temperature | 37 C |
| Cell Density at Seeding | 7-10 x 10^4 cells/ml | Methods for Passages | dilution |
| Doubling Time | 21 hrs | Cell Number in Vial (cells/1ml) | 1.1 x 10^6 |
| Viability at cell freezing (%) | 91 | Antibiotics Used | free |
| Passage Number | P7 at bank | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | No | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0163 | Cell Name | HL60(S) |
|---|---|---|---|
| LOT No. | 04192001 | Lot Specification | distribution |
| Medium | RPMI1640 medium with 10 or 20% heat inactivated fetal bovine serum (Intergen RB52405). | Temperature | 37 C |
| Cell Density at Seeding | 2.0 x 10^5 cells/ml | Methods for Passages | Simple dilution. split ratio=1/4. Subculture every 3-4 days. |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.8 x 10^6 |
| Viability at cell freezing (%) | 94.1 | Antibiotics Used | free |
| Passage Number | P3* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | |
| Adhesion | No | Exoteric Gene | NT |
| Medium for Freezing | Culture medium containing 5 % DMSO. | CO2 Conc. | 5 % |
| Viability immediately after thawing (%) | Additional information |
| Images |
|---|
![]() ![]() ![]() ![]() ![]() ![]() |
| Cell No. | JCRB0163 | Cell Name | HL60(S) |
|---|---|---|---|
| LOT No. | 04112017 | Lot Specification | distribution |
| Medium | RPMI 1640 medium with 10 - 20% fetal bovine serum. At log growth phase, serum contents can be decreased to 5%. (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
| Cell Density at Seeding | approx. 1 x 10^5 cells/ml | Methods for Passages | Simple dilution (suspension culture). |
| Doubling Time | approx. 18 hrs. | Cell Number in Vial (cells/1ml) | 2.8 x 10^6 |
| Viability at cell freezing (%) | 88.1 | Antibiotics Used | free |
| Passage Number | Unknown (6 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | No | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 88.1 | Additional information |
| Cell No. | JCRB0163 | Cell Name | HL60(S) |
|---|---|---|---|
| LOT No. | 10212022 | Lot Specification | distribution |
| Medium | RPMI1640(GIBCO Cat#11875-093) with 10% heat inactivated fetal bovine serum (SIGMA, Cat#172012, Lot#12J396) | Temperature | 37 C |
| Cell Density at Seeding | 1.76-3.0x10^4 cells/ml | Methods for Passages | dilution |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.68x10^6 |
| Viability at cell freezing (%) | 84 | Antibiotics Used | free |
| Passage Number | p6* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:12 D13S317:8,11 D7S820:11,12 D16S539:11 VWA:16 TH01:7,8 AM:X TPOX:8,11 CSF1PO:13,14 |
| Adhesion | No | Exoteric Gene | NT |
| Medium for Freezing | BAMBANKER (LYMPHOTEC Inc., CS-02-001, NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 90 | Additional information |
| Images |
|---|
![]() ![]() ![]() |














